Skip to main navigation Skip to search Skip to main content

Insulinoma in Cats

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter discusses pathogenesis, classical signs, diagnosis, treatment, and prognosis for insulinoma in cats. Insulinomas are functional tumors of the pancreatic beta cells that autonomously synthesize and secrete insulin, even in the face of hypoglycemia. This predisposes animals to hypoglycemic crises during fasting and exercise. These tumors retain some responsiveness to many of the normal stimuli for insulin secretion, but demonstrate an exaggerated response. Therefore, animals with insulinoma are at risk of hypoglycemia after eating or with the administration of glucose containing intravenous fluids. Clinical signs are generally present for weeks to months prior to investigation. They typically included seizures, lethargy, weakness, muscle twitching, and collapse, although inappetence, diarrhea, and weight loss have also been reported Hematological abnormalities have rarely been reported in cases of insulinoma; those documented include anemia and mild thrombocytopenia. The prognosis for cats with insulinoma appears highly variable.

Original languageEnglish (US)
Title of host publicationClinical Endocrinology of Companion Animals
PublisherWiley-Blackwell
Pages240-244
Number of pages5
ISBN (Electronic)9781118997093
ISBN (Print)9780813805832
DOIs
StatePublished - Jan 22 2013
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2013 by John Wiley & Sons, Inc.

Keywords

  • Cats
  • Hypoglycemia
  • Insulin
  • Insulinoma
  • Prognosis
  • Treatment

Fingerprint

Dive into the research topics of 'Insulinoma in Cats'. Together they form a unique fingerprint.

Cite this